Should an 86-year-old discontinue Remeron (mirtazapine) 45 mg by tapering rather than stopping abruptly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should You Taper Remeron 45mg in an 86-Year-Old?

Yes, you absolutely need to taper Remeron (mirtazapine) 45mg before discontinuing it in an 86-year-old patient—abrupt cessation can cause a discontinuation syndrome with potentially serious symptoms. 1

Why Tapering is Essential

The FDA drug label for Remeron explicitly warns against abrupt discontinuation 1. When stopped suddenly, patients can experience:

  • Dizziness and sensory disturbances (including paresthesia and electric shock sensations)
  • Psychological symptoms: agitation, anxiety, confusion
  • Physical symptoms: headache, tremor, nausea, vomiting, sweating
  • Sleep disturbances: abnormal dreams, insomnia

This is particularly important in elderly patients like your 86-year-old, who may be more vulnerable to these withdrawal effects and their complications (falls, confusion, dehydration).

How to Taper Safely

Recommended Tapering Approach:

Start with gradual dose reduction rather than abrupt cessation 1. While specific mirtazapine tapering protocols aren't detailed in the evidence, general antidepressant tapering principles apply 2:

  • Begin with 10% dose reductions at weekly intervals as a starting point
  • For elderly patients on long-term therapy, consider slower tapers: 10% per month or even slower 3, 4
  • Monitor closely for withdrawal symptoms at each dose level
  • Pause the taper if significant withdrawal symptoms emerge, then resume more slowly when tolerated

Practical Tapering Schedule for 45mg:

  1. Week 1-2: Reduce to 30mg daily
  2. Week 3-4: Reduce to 15mg daily
  3. Week 5-6: Reduce to 7.5mg daily (half of 15mg tablet)
  4. Week 7+: Consider extending dosing intervals (every other day) before complete discontinuation

If the patient has been on mirtazapine for years, stretch this timeline to monthly reductions instead of weekly.

Adjunctive Measures During Tapering

To minimize withdrawal symptoms 4:

  • For anxiety/insomnia: Consider short-term use of trazodone or gabapentin (avoid benzodiazepines in elderly)
  • For GI symptoms: Supportive care as needed
  • Maintain close follow-up: Weekly initially, then as clinically indicated

Critical Caveats for Elderly Patients

In an 86-year-old, pay special attention to:

  • Fall risk: Withdrawal symptoms like dizziness increase fall risk in elderly 1
  • Cardiovascular concerns: Monitor for orthostatic hypotension, which mirtazapine can cause and withdrawal may unmask 1
  • Cognitive changes: Confusion or memory impairment during withdrawal may be mistaken for dementia progression
  • Ensure adequate support: Patient should not be alone during initial taper phases

When to Taper More Slowly

Extend the taper timeline (months rather than weeks) if 5, 4:

  • Patient has taken mirtazapine for >1 year
  • Previous failed taper attempts
  • History of severe depression or anxiety
  • Multiple comorbidities or frailty
  • Patient expresses significant anxiety about discontinuation

The goal is patient comfort and successful discontinuation, not speed. 4

Monitoring Plan

Essential monitoring during taper:

  • Weekly check-ins (phone or in-person) during active dose reductions
  • Assess for withdrawal symptoms at each contact
  • Monitor mood and sleep quality
  • Watch for return of original symptoms (depression, insomnia, anxiety)
  • Have patient/caregiver report any concerning symptoms immediately

Never abruptly stop mirtazapine—the risk of discontinuation syndrome is real and can significantly impact quality of life and safety, especially in elderly patients. 1

References

Guideline

a practical approach to using adjuvant analgesics in older adults.

Journal of the American Geriatrics Society (JAGS), 2020

Guideline

prevention and control of seasonal influenza with vaccines.

MMWR Recommendations and Reports, 2016

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.